Skip Nav Destination
Issues
1 January 2000
ISSN 1078-0432
EISSN 1557-3265
Advances in Brief
Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study1
George J. Brewer; Robert D. Dick; Damanjit K. Grover; Virginia LeClaire; Michael Tseng; Max Wicha; Kenneth Pienta; Bruce G. Redman; Thierry Jahan; Vernon K. Sondak; Myla Strawderman; Gerald LeCarpentier; Sofia D. Merajver
Clinical Trials
A Phase I and Pharmacokinetic Study of the Mitochondrial-specific Rhodacyanine Dye Analog MKT 0771
Carolyn D. Britten; Eric K. Rowinsky; Sharyn D. Baker; Geoffrey R. Weiss; Lon Smith; Joseph Stephenson; Mace Rothenberg; Leslie Smetzer; Jeffrey Cramer; William Collins; Daniel D. Von Hoff; S. Gail Eckhardt
TP53 Mutation and p53 Overexpression for Prediction of Response to Neoadjuvant Treatment in Breast Cancer Patients1
Daniela Kandioler-Eckersberger; Carmen Ludwig; Margarethe Rudas; Sonja Kappel; Elisabeth Janschek; Catharina Wenzel; Hermine Schlagbauer-Wadl; Martina Mittlböck; Michael Gnant; Günter Steger; Raimund Jakesz
A Phase I and Pharmacokinetic Study of Docetaxel Administered in Combination with Continuous Intravenous Infusion of 5-Fluorouracil in Patients with Advanced Solid Tumors1
Eric Van Den Neste; Dominique de Valeriola; Joseph Kerger; Harry Bleiberg; Zlatko Kusenda; Christiane Brassinne; Sylvie Bartholomeus; Jean Selleslags; Philippe Hennebert; Hilda Wythouck; Isabelle Cazenave; Florence Lefresne-Soulas; Martine Piccart
Phase I Trial of Exisulind (Sulindac Sulfone, FGN-1) as a Chemopreventive Agent in Patients with Familial Adenomatous Polyposis1
Rosalind van Stolk; Gary Stoner; William L. Hayton; Kenneth Chan; Barry DeYoung; Laura Kresty; Brian H. Kemmenoe; Paul Elson; Lisa Rybicki; James Church; Kim Provencher; Denise McLain; Ernest Hawk; Ben Fryer; Gary Kelloff; Ram Ganapathi; G. Thomas Budd
Patients Treated with Antitumor Drugs Displaying Neurological Deficits Are Characterized by a Low Circulating Level of Nerve Growth Factor1
Stefano De Santis; Andrea Pace; Loredana Bove; Francesco Cognetti; Francesca Properzi; Marco Fiore; Viviana Triaca; Antonella Savarese; Maria Domenica Simone; Bruno Jandolo; Luigi Manzione; Luigi Aloe
Molecular Oncology, Markers, Clinical Correlates
Correlations Among p53, Her-2/neu, and ras Overexpression and Aneuploidy by Multiparameter Flow Cytometry in Human Breast Cancer: Evidence for a Common Phenotypic Evolutionary Pattern in Infiltrating Ductal Carcinomas1
Charles A. Smith; Agnese A. Pollice; Ling-Ping Gu; Kathryn A. Brown; Sarita G. Singh; Laura E. Janocko; Ronald Johnson; Thomas Julian; David Hyams; Norman Wolmark; Lillian Sweeney; Jan F. Silverman; Stanley E. Shackney
Prognostic Significance of DNA Ploidy, S-Phase Fraction, and Tissue Levels of Aspartic, Cysteine, and Serine Proteases in Operable Gastric Carcinoma1
Antonio Russo; Viviana Bazan; Manuela Migliavacca; Ines Zanna; Carla Tubiolo; Francesca Maria Tumminello; Gabriella Dardanoni; Massimo Cajozzo; Pietro Bazan; Giuseppe Modica; Mario Latteri; Rosa Maria Tomasino; Giuseppe Colucci; Nicola Gebbia; Gaetano Leto
Experimental Therapeutics, Preclinical Pharmacology
E1A-mediated Paclitaxel Sensitization in HER-2/neu-overexpressing Ovarian Cancer SKOV3.ip1 through Apoptosis Involving the Caspase-3 Pathway1
Naoto T. Ueno; Chandra Bartholomeusz; John L. Herrmann; Zeev Estrov; Ruping Shao; Michael Andreeff; Janet Price; Ralph W. Paul; Pervin Anklesaria; Dihua Yu; Mien-Chie Hung
Letters to the Editor
Advertisement